Welcome
We help health technology companies navigate the journey from evidence generation to commercialisation with confidence. We support companies of all sizes to identify payers and generate evidence that matches their expectations while developing and executing on the wider commercial strategy.
We believe:
- Health technologies should be robustly evidenced to appropriate regulatory, clinical and cost effectiveness standards
- That these technologies should be reimbursed at scale
- That patients and clinicians should have widespread access to these evidenced technologies
The team combines clinical, market access, health technology assessment, regulatory, and commercial expertise to hand hold clients on the end-to-end journey from ideation to scale. We have experience with:
- Regulated medical devices (including software as a medical device and AI as a medical device)
- Non-clinical and sub-clinical products
- Both B2B and B2C products
- Hardware and digital products including combination devices and therapies
We cover the UK, mainland Europe and North America and partner with healthcare providers, investors and accelerators.